Our recent studies have demonstrated that PPAR alpha activators stimulate d
ifferentiation and inhibit proliferation in cultured human keratinocytes an
d accelerate epidermal development and permeability barrier formation in fe
tal rat skin explants. As the role of PPAR alpha activation in adult epider
mis is not known, the aim of this study was to determine if topically appli
ed PPAR alpha ligands regulate keratinocyte differentiation in murine epide
rmis. Topical treatment with PPAR alpha activators resulted in decreased ep
idermal thickness. Expression of structural proteins of the upper spinous/g
ranular layers (involucrin, profilaggrin-filaggrin, loricrin) increased fol
lowing topical treatment with PPAR alpha activators. Furthermore, topically
applied PPAR alpha activators also increased apoptosis, decreased cell pro
liferation, and accelerated recovery of barrier function following acute ba
rrier abrogation. Experiments with PPAR alpha(-/-) knockout mice showed tha
t these effects are specifically mediated via PPAR alpha. Compared with the
epidermis of PPAR alpha(+/+) mice, involucrin, profilaggrin-filaggrin, and
loricrin expression were slightly decreased in PPAR alpha-/- mice. Moreove
r, topical clofibrate treatment did not increase epidermal differentiation
in PPAR alpha-/- mice. Furthermore, in cultured human keratinocytes we have
demonstrated that PPAR alpha activators induce an increase in involucrin m
RNA levels. We have also shown that this increase in gene expression requir
es an intact AP-1 response element at -2117 to -2111 bp. Thus, stimulation
of PPAR alpha stimulates keratinocyte/epidermal differentiation and inhibit
s proliferation.